Research map: Clonal evolution driving timing and sites of postsurgical recurrences in hepatocellular carcinoma

Back to the article

Papers in this map

  1. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma · Yun‐Fan Sun · 2020 · 968 citations · Cited by this paper
  2. A patient-driven agenda for liver cirrhosis research · 2026 · Related
  3. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma · Josep Maria Llovet · 2024 · 376 citations · Cited by this paper
  4. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · 2026 · Related
  5. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas · Xiaofan Ding · 2019 · 222 citations · Cited by this paper
  6. Toward a CKLM framework for integrated clinical trial design · 2026 · Related
  7. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update · María Reig · 2025 · 194 citations · Cited by this paper
  8. Large language models for detecting colorectal polyps in endoscopic images—further research is required · 2026 · Related
  9. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial · Kang Wang · 2024 · 137 citations · Cited by this paper
  10. USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · 2026 · Related
  11. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy · Ziyi Li · 2024 · 97 citations · Cited by this paper
  12. Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · 2026 · Related
  13. Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences · Shuling Chen · 2023 · 75 citations · Cited by this paper
  14. Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · 2026 · Related
  15. Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial · Zheng Wang · 2025 · 58 citations · Cited by this paper
  16. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · 2026 · Related
  17. Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma · Adam Charles Yopp · 2026 · 35 citations · Cited by this paper
  18. Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · 2026 · Related
  19. Clonal diversity underpins distinct modes of recurrence in hepatocellular carcinoma: the PLANet cohort study · Ying Zhang · 2026 · 2 citations · Cited by this paper
  20. Untitled · Cited by this paper

Source: OpenAlex (CC0)